Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: United States Clear all

686 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20027
200311
200415
200518
200628
200730
200836
200928
201029
201122
201221
201319
201423
201557
201632
201737
201842
201938
202033
202151
202241
202334
202420
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated686

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer34
National Cancer Institute (NCI)32
Novartis Pharmaceuticals22
M.D. Anderson Cancer Center15
Bristol-Myers Squibb9
GlaxoSmithKline9
Incyte Corporation9
Vanderbilt-Ingram Cancer Center9
Washington University School of Medicine9
Clovis Oncology, Inc.8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung686
Lung Neoplasms186
Melanoma79
Colorectal Neoplasms70
Neoplasm Metastasis60
Neoplasms58
Squamous Cell Carcinoma of Head and Neck54
Ovarian Neoplasms52
Carcinoma, Renal Cell47
Breast Neoplasms42

Trials

Showing 1 to 25 of 686. Each trial links to its page on Pharma Observatory.

586 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.